Cyclophosphamide
RG1122036
Phase 1 small_molecule active
Quick answer
Cyclophosphamide for Recurrent Diffuse Large B-Cell Lymphoma is a Phase 1 program (small_molecule) at Nektar Therapeutics UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Nektar Therapeutics UK Limited
- Indication
- Recurrent Diffuse Large B-Cell Lymphoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active